Anastrozole is better at preventing the spread and return of breast cancer than tamoxifen, reported seven newspapers . The newspapers accurately reported the results of a large well-conducted trial, which concluded that anastrozole should be the first line adjuvant treatment for postmenopausal women with early breast cancer.
Anastrozole is better at preventing the spread and return of breast cancer than tamoxifen, reported seven newspapers . The newspapers accurately reported the results of a large well-conducted trial, which concluded that anastrozole should be the first line adjuvant treatment for postmenopausal women with early breast cancer.
http://www.nelh.nhs.uk/hth/breast_cancer_drug_5.asp
